Primary Record
Galunisertib
- In stock
- 3,840 g
- Purity
- 99.5 %
- CAS
- 700874-72-2
Compound Identifiers & Properties
- CAS
- 700874-72-2
- PubChem CID
- 10090485
- SMILES
- CC1=NC(=CC=C1)C2=NN3CCCC3=C2C4=C5C=C(C=CC5=NC=C4)C(=O)N
- Canonical SMILES
- Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1
Names & Synonyms
- Galunisertib
- 700874-72-2
- LY2157299
- galunisertibum
- LY 2157299
- LY-2157299
- TGF beta
- Galunisertib [USAN]
- UNII-3OKH1W5LZE
- 3OKH1W5LZE
- ly2157299(galunisertib)
- cc-8
- Galunisertib [USAN:INN]
- RefChem:142227
- Galunisertib (LY2157299)
- Galunisertib (USAN/INN)
- GALUNISERTIB [INN]
- D06TFI
- DTXSID00220362
- 4-(2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-6-carboxamide
- MFCD12923319
- C22H19N5O
- GALUNISERTIB [WHO-DD]
- CHEBI:137064
- GTPL7797
- LY2157299(Galunisertib)?
- orb1305376
- CHEMBL2364611
- SCHEMBL12922153
- SCHEMBL29362145
- CTK2G3146
- AMY9045
- DTXCID00142853
- EX-A009
- QCR-234
- IVRXNBXKWIJUQB-UHFFFAOYSA-N
- GLXC-90145
- HMS3655D14
- AOB87326
- BCP02173
- EBD30286
- ZINC3959536
- BDBM50015640
- NSC761216
- NSC800103
- s2230
- AKOS022175280
- ACN-029581
- CCG-264950
- CS-0474
- DB11911
- EX-8675
- FM43366
- NSC-761216
- NSC-800103
- RL04686
- SB16483
- CID10090485
- LYL-2157299
- NCGC00384167-07
- AC-31327
- AJ-47534
- AK-79916
- AS-42940
- BC638676
- CID:10090485
- CJ-11234
- HY-13226
- inhibitor 15d [PMID: 18314943]
- SC-85597
- SID:375590862
- AB0033807
- 4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]quinoline-6-carboxamide
- A8348
- FT-0741808
- NS00069665
- SW219460-1
- X7574
- J2.999.611C
- A11017
- D10437
- W-5548
- 4-[2-(6-methylpyridin-2-yl)-4H,5H,6H-pyrrolo[1,2-b]pyrazol-3-yl]quinoline-6-carboxamide
- A836766
- C557799
- 4-(2-(6-Methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo-[1,2-b]pyrazol-3-yl)quinoline-6-carboxamide
- 4-[5,6-Dihydro-2-(6-methyl-2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-6-quinolinecarboxamide
- BRD-K78118466-001-03-3
- Q27077768
- 2-(6-Methyl-pyridin-2-yl)-1-quinoxalin-6-yl-ethanone
- B0084-307752
- 4-(2-(6-Methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo(1,2-b)pyrazol-3-yl)quinoline-6-carboxylic acid amide
- 6-Quinolinecarboxamide, 4-(5,6-dihydro-2-(6-methyl-2-pyridinyl)-4H-pyrrolo(1,2-b)pyrazol-3-yl)-
- 6-Quinolinecarboxamide, 4-[5,6-dihydro-2-(6-methyl-2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-
- LY-2157299,LY 2157299, 700874-72-2
- 4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]quinoline
- Galunisertib, 98%, a potent TGF-beta receptor I (TbetaRI) inhibitor - 10MG 10mg
- 2-(6-Methyl-Pyridin-2-Yl)-3-[6-Amido-Quinolin-4-Yl)-5,6-Dihydro-4H-Pyrrolo[1,2-B]Pyrazole
- 2-(6-methylpyridin-2-yl)-3-(6-aminocarbonylquinolin-4-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole
- 4-(2-(6-METHYLPYRIDIN-2-YL)-5,6-DIHYDRO-4H-PYRROLO(1,2-B)PYRAZOL-3-YL)QUINOLINE-6-CARBOXAMIDE
- 4-(2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo(2,1-e)pyrazol-3-yl)quinoline-6-carboxamide
- 4-[2-(6-Methyl-2-Pyridinyl)-5,6-Dihydro-4H-Pyrrolo[1,2-B]Pyrazol-3-Yl]-6-Quinolinecarboxamideorly215
- 4-[2-(6-methyl-2-pyridinyl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]-6-quinolinecarboxamideorLY2157299
- 4-[2-(6-Methyl-2-pyridinyl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole-3-yl]quinoline-6-carboxamide
- 4-[2-(6-methyl-2-pyridyl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]quinoline-6-carboxamide
- 4-[2-(6-Methyl-pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]-quinoline-6-carboxylic acid amide
- 4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[2,1-e]pyrazol-3-yl]quinoline-6-carboxamide
- 4-[5,6-Dihydro-2-(6-methyl-2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazole-3-yl]-6-quinolinecarboxamide
- 4-[7-(6-methylpyridin-2-yl)-1,8-diazabicyclo[3.3.0]octa-5,7-dien-6-yl]quinoline-6-carboxamide
- 6-QUINOLINECARBOXAMIDE, 4-(5,6-DIHYDRO-2-(6-METHYL-2-PYRIDINYL)-4H-PYRROLO(1,2-B)PYRAZOL-3-YL)-)
- 912477-03-3
- LY2157299; 4-(2-(6-Methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-6-carboxamide; 4-[5,6-Dihydro-2-(6-methyl-2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-6-quinolinecarboxamide